Global Hematology Analyzers and Reagents: Overview
Hematology analyzers and reagents are a medical reagent that needs to use in conjunction with a blood cell analyzer. It is mainly used for clinical detection of blood cell count, hemoglobin content, and blood cell classification. Medical reagents such as blood cell reagents are clinically consumable reagents and are widely used in hospitals around the world.
Fully automatic biochemical analyzers and medical equipment are widely used in hospitals at all levels, and the fast and accurate results also provide a great convenience for clinical diagnosis. The blood cell reagent is a kind of liquid with a certain pH, appropriate osmotic pressure, conductivity, and electrolyte balance. It is diluted with human blood cells in a certain proportion, which can maintain the normal physiological shape of human blood cells, and it is not easy to disperse. Reagents exceeding the expiration date or improperly stored may cause calibration errors and cause systematic errors in the test results.
Global Hematology Analyzers and Reagents: Insights
The global hematology analyzers and reagent market size exceeded USD 7.58 billion in 2019 and projected to generate revenue of USD 13.02 billion by 2027, with CAGR of over 6.72% between 2020 to 2027. The growth in blood and the surge in the incidence of blood disorders along with the technological advancements in hematology analyzer are key factors estimated to drive the growth of the global hematology analyzers and reagent market. Moreover, the increasing adoption of automated hematology instruments, along with the growing preferences towards high sensitivity point-of-care (POC) is boosting the growth. Additionally, the upsurge in demand for blood banks witnessing a huge outflow of blood units to hospitals is one of the significant factors enhancing market growth.
A blood analyzer has become a complete blood count (complete blood count, CBC) essential equipment. It will not only reduce the labor intensity of staff, improve the accuracy of test results, but also provide more relevant laboratory parameters, diseases. Further, the integration of the flow cytometry techniques with hematology analyzers is projected to fuel the growth of the global hematology analyzers and reagent industry. Also, the growing adoption of the microfluidics technology in hematology analyzer along with the introduction of the digital imaging system in hematology would create a robust impact on the growth of the market in the upcoming years. In addition, the surge in the geriatric population along with the increasing incidence of thalassemia, sickle cell anemia & leukemia will spur the growth of hematology analyzers and reagents industry.
Moreover, the rapid adoption of the automation of hematology analyzers in emerging nations will enhance the demand for hematology analyzers and reagent in the next few years. Further, the upsurge in demand for automated systems, especially in conducting reticulocyte analysis and coagulation tests, will accelerate the growth of the market. The growing demand for hematology analyzers in detecting rare blood conditions such as eosinophilia and histiocytosis, by measuring the cell morphology and detecting small cell populations will drive the global hematology analyzers and reagent industry in the future time.
The SPER market research report of the Hematology Analyzers and Reagents includes all integrated approaches to the growth of the market, along with an accurate & elaborate analysis of the complete competitive situation of this market on a global level. Besides the current analytical & statistical account, the report cloaks the trends market drivers, challenges, potential opportunities, which affect the market. This market report discusses the present situation to predicted trends & aspects of the growth of the Hematology Analyzers and Reagents. Furthermore, it gives a dynamic overview & insights related to the market at both global as well as regional scales.
Global Hematology Analyzers and Reagents: Product & Services Insight
Based on the product & services, the global hematology analyzers and reagents bifurcated into Instruments (5-Part and 6-Part Fully Automated, 3-Part Fully Automated, Semi-Automated, Point-Of-Care Testing), and Reagents & Consumables (Hematology Reagents, Slide Stainers/Makers, Controls and Calibrators and Consumables) and Services. The Instruments segment accounted for a major market share in 2019 and is projected to witness substantial growth in the coming years. It is due to the growing adoption of POC testing hematology analyzers in developing countries, along with the rising preference towards automation, and increasing trend of the reagent rental’ business model.
Global Hematology Analyzers and Reagents: Price Range Insights
Based on the price range, the global hematology analyzers and reagents segregated into high-end hematology analyzers, mid-range hematology analyzers, and low-end hematology analyzers. The high-end hematology analyzers are estimated to grow significantly from 2020 to 2027, owing to its benefits such as reliability, high accuracy, flexibility, ease of use, and multi-parameter testing capability.
Global Hematology Analyzers and Reagents: Application Insights
Based on the application, the global hematology analyzers and reagents classified into Anaemia, Blood Cancer, Hemorrhagic Conditions, Infection Related Conditions, Immune System Related Conditions, and Other Applications. The Anaemia segment anticipated dominating the market by 2027. It is due to the automation hematology help in analyze whole blood specimens for the complete blood count (CBC), which red blood cell (RBC) count, white blood cell count, platelet count, hemoglobin concentration, hematocrit, and RBC indices.
Global Hematology Analyzers and Reagents: End-User Insights
Based on the end-user, the global hematology analyzers and reagents categorized into hospital laboratories, commercial service providers, government reference laboratories, and research and academic institutes. The hospital laboratories segment estimated to generate maximum revenue by 2027, on account of the rise in adoption of hematology analyzers and reagents for growing prevalence of blood-related disorders such as hereditary spherocytosis, chronic granulomatous disease, chronic lead poisoning, and sickle cell disease.
Global Hematology Analyzers and Reagents: Regional Insight
By geography, the global hematology analyzers and reagents segmented into North America, Europe, Asia Pacific, South America, and Middle East & Africa. North America captured the largest share of the global hematology analyzers and reagents market in 2019. It is due to the increasing incidence of blood disorders, the high number of patients with blood coagulation disorders, and the growing demand for blood transfusions in the region.
The report presents a detailed assessment of the various factors influencing the market's trajectory into 2020 and 2027. It covers all the crucial information of the leading companies operating in the global Hematology Analyzers and Reagents. Besides highlighting the product offerings, the report also calculates revenue generated over the period and their position in the market.
REPORT HIGHLIGHTS
- Overview of key market forces restraining and propelling market growth.
- Provide demand, current & past status & also the forecasting up to 2027.
- Provide complete overview including, Product & Services, price-range, application, end-user & forecast region.
- Provide focused analysis of key service providers with their market share & also help to identify market competition landscape with SWOT analysis.
- Historical, current, and projected market size in terms of value.
- Analyse the global & regional potential market, advantages, risk & opportunity.
- Identify significant factors and trends driving or inhibiting the market growth.
- In-depth coverage of the complete market in terms of supplier, buyer, price, trend, growth & forecasting.
THE REPORT COVERS ANALYSIS OF HEMATOLOGY ANALYZERS AND REAGENTS, BY PRODUCT & SERVICE
- Instruments
- Reagents & Consumables
- Services
THE REPORT COVERS ANALYSIS OF HEMATOLOGY ANALYZERS AND REAGENTS, BY PRICE-RANGE
- High-End Hematology Analyzers
- Mid-Range Hematology Analyzers
- Low-End Hematology Analyzers
THE REPORT COVERS ANALYSIS OF HEMATOLOGY ANALYZERS AND REAGENTS, BY APPLICATION
- Anemia
- Blood Cancer
- Hemorrhagic Conditions
- Infection Related Conditions
- Immune System Related Conditions
- Other Applications
THE REPORT COVERS ANALYSIS OF HEMATOLOGY ANALYZERS AND REAGENTS, BY END-USER
- Hospital Laboratories
- Commercial Service Providers
- Government Reference Laboratories
- Research and Academic Institutes
THE REPORT COVERS EXHAUSTIVE ANALYSIS ON
- Market Segments
- Market Dynamics
- Brands in Market
- Market Size
- Current Trends/Issues/Challenges
- Competition & Companies Involved
- Forecasting
- Technology
THE REPORT INCLUDES REGIONAL ANALYSIS ON
- North America (Canada, US, Mexico, & Rest of North America Available)
- Asia-Pacific (China, India, South Korea, Japan & Rest of Asia Pacific Available)
- Europe (Germany, Spain, France, United Kingdom & Rest of Europe Available)
- Central & South America (Brazil, Argentina & Rest of South America Available)
- Middle East & Africa (GCC Countries, South Africa, & Rest of MEA available)
KEY PLAYERS OF HEMATOLOGY ANALYZERS AND REAGENTS
- Sysmex
- Danaher
- Nihon Kohden
- Siemens
- Abbott Laboratories
- Boule Diagnostics
- HORIBA
- Bio-Rad Laboratories
- BioSystems
- Diatron
- Drew Scientific
- EKF Diagnostics
- Mindray
- Ortho Clinical Diagnostics
- Roche
- Other Prominent Players
1. Introduction
2. Research Methodology
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact of the Hematology Analyzers and Reagents Market
4.4. Market Trends
5. Global Hematology Analyzers and Reagents Market, By Product & Services, 2021-2027 (USD Million)
5.1. Instruments
5.1.1. 5-Part & 6-Part Fully Automated
5.1.2. 3-Part Fully Automated
5.1.3. Semi Automated
5.1.4. Point-of-care Testing
5.2. Reagents & Consumables
5.2.1. Hematology Reagents
5.2.2. Slide Stainers/Makers
5.2.3. Controls & Calibrators
5.2.4. Consumables
6. Global Hematology Analyzers and Reagents Market, By Price Range, 2021-2027 (USD Million)
6.1. High end Hematology Analyzers
6.2. Medium end Hematology Analyzers
6.3. Low end Hematology Analyzers
7. Global Hematology Analyzers and Reagents Market, By Application, 2021-2027 (USD Million)
7.1. Anemia
7.2. Blood Cancer
7.3. Hemorrhagic Conditions
7.4. Infection Related Conditions
7.5. Immune System Related Conditions
7.6. Other Applications
8. Global Hematology Analyzers and Reagents Market, By End User, 2021-2027 (USD Million)
8.1. Hospital Laboratories
8.2. Commercial Service Providers
8.3. Government Reference Laboratories
8.4. Research and Academic Institutes
9. Global Hematology Analyzers and Reagents Market, By Geography, 2021-2027 (USD Million)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. UK
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. Japan
9.3.3. India
9.3.4. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Latin America
9.4.2. Middle East & Africa
10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis, By Key Players (2019)
10.3. Competitive Scenario
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments
11. Company Profiles
11.1. Abbott Laboratories
11.2. Bio-Rad Laboratories
11.3. BioSystems
11.4. Boule Diagnostics
11.5. Danaher Corporation
11.6. Diatron
11.7. Drew Scientific
11.8. EKF Diagnostics
11.9. HORIBA
11.10. Mindray
11.11. Nihon Kohden
11.12. Ortho Clinical Diagnostics
11.13. Roche
11.14. Siemens
11.15. Sysmex Corporation
12. Appendix